|
Items reviewed, n (%)
|
Proportion with an error, n (%)
|
Proportion with suboptimal prescribing, n (%)
|
Chapter of the British National Formulary
|
Chapter 1: Gastro-intestinal system | 112 (10.9) | 5 (4.5) | 36 (32.1) |
Chapter 2: Cardiovascular system | 121 (11.8) | 2 (1.7) | 15 (12.4) |
Chapter 3: Respiratory system | 65 (6.3) | 6 (9.2) | 22 (33.8) |
Chapter 4: Central nervous system | 201 (19.6) | 27 (13.4) | 53 (26.4) |
Chapter 5: Infections | 183 (17.8) | 27 (14.8) | 65 (35.5) |
Chapter 6: Endocrine system | 46 (4.5) | 3 (6.5) | 25 (54.3) |
Chapter 7: Obstetrics, gynaecology, and urinary-tract disorders | 39 (3.8) | 0 (0) | 11 (28.2) |
Chapter 8: Malignant disease and immunosuppression | 1 (0.1) | 0 (0) | 0 (0) |
Chapter 9: Nutrition and blood | 9 (0.9) | 1 (11.1) | 4 (44.4) |
Chapter 10: Musculoskeletal and joint diseases | 66 (6.4) | 4 (6.1) | 22 (33.3) |
Chapter 11: Eye | 16 (1.6) | 3 (18.8) | 13 (81.3) |
Chapter 12: Ear, nose, and oropharynx | 40 (3.9) | 2 (5.0) | 30 (75.0) |
Chapter 13: Skin | 125 (12.2) | 12 (9.6) | 61 (48.8) |
Chapter 14: Immunological products and vaccines | 1 (0.1) | 0 (0) | 0 (0) |
Chapter 15: Anaesthesia | 3 (0.3) | 0 (0) | 3 (100.0) |
Total
|
1028 (100.0) |
92 (8.9) |
360 (35.0) |
|
Items reviewed, n (%)
|
Proportion with an error, n (%)
|
Proportion with suboptimal prescribing, n (%)
|
Formulation type
|
Solid oral | 681 (66.2) | 44 (6.5) | 195 (28.6) |
Topical | 173 (16.8) | 14 (8.1) | 92 (53.2) |
Liquid oral | 68 (6.6) | 24 (35.3) | 21 (30.9) |
Inhalers | 48 (4.7) | 6 (12.5) | 20 (41.7) |
Eye or ear | 30 (2.9) | 4 (13.3) | 25 (83.3) |
Vaginal | 12 (1.2) | 0 (0) | 6 (50.0) |
Devices | 11 (1.1) | 0 (0) | 0 (0) |
Injections | 3 (0.3) | 0 (0) | 0 (0) |
Rectal | 2 (0.2) | 0 (0) | 1 (50.0) |
Total
|
1028 (100.0) |
92 (8.9) |
360 (35.0) |
Drug status
|
New acute (NA) | 666 (64.8) | 65 (9.8) | 271 (40.7) |
Reissued acute (RA) | 84 (8.2) | 10 (11.9) | 34 (40.5) |
New repeat (NR) | 65 (6.3) | 1 (1.5) | 17 (26.2) |
Amended repeat (AR) | 3 (0.3) | 0 (0) | 1 (33.3) |
Reissued repeat (RR) | 210 (20.4) | 16 (7.6) | 37 (17.6) |
Total
|
1028 (100.0) |
92 (8.9) |
360 (35.0) |